Adopting healthy lifestyle habits can significantly improve heart health—even if the number on the scale doesn’t change much. That’s the conclusion of a new study published in the European Journal of Preventive Cardiology, which examined how varying levels of weight loss from long-term lifestyle interventions affected cardiometabolic health.
Lifestyle Change Benefits Go Beyond the Scale
Weight loss is widely recognized as a key factor in reducing the risk of cardiometabolic diseases, including type 2 diabetes, cardiovascular disease, hypertension, and premature death. Losing at least 5% of body weight has been linked to positive changes in body fat, waist circumference, HDL (“good”) cholesterol, and blood pressure.
However, maintaining weight loss remains challenging. Many people regain most of the weight within one to five years due to metabolic adaptation, hormonal shifts, and behavioral relapse. Individual responses to lifestyle-based weight loss interventions vary widely due to differences in behavior, metabolism, and genetics, prompting a growing call for more personalized approaches.
Study Design and Participant Groups
Researchers pooled data from three major long-term lifestyle intervention trials, each using different dietary and behavioral strategies but showing similar patterns in weight change and health outcomes. Participants were grouped into three categories based on their weight change during the study:
Successful weight loss: More than 5% reduction in body weight
Moderate weight loss: Between 0% and 5% reduction
Weight loss resistant: No weight loss or weight gain
Participants underwent multiple assessments during the trials, including physical measurements, blood pressure, and fasting blood biomarkers. In two of the trials, MRI imaging was used to evaluate visceral and liver fat. Data was recorded at baseline, six months, and at the end of the intervention (18 or 24 months).
A sub-study also explored potential predictors of weight loss success using baseline biological data, including DNA methylation, proteomics, and metabolomics. Researchers applied cross-trial association studies and elastic net regression for predictive modeling. Statistical analyses included chi-square tests, ANOVA, paired t-tests, and multivariate regression, with adjustments for outliers and multiple comparisons.
Key Findings
At baseline, participants in the weight loss-resistant group tended to be younger, more likely female, and had lower waist circumference, liver enzymes, and intrahepatic fat. However, after adjusting for trial, BMI, age, and sex, these differences were no longer statistically significant.
Predictive models based on pre-intervention omics data—including DNA methylation, proteins, and metabolites—generally performed poorly in forecasting weight loss outcomes. Only 12 specific DNA methylation sites showed moderate predictive accuracy in subgroup analysis. While promising, these findings remain exploratory and are not yet ready for clinical use.
Despite varied weight loss outcomes, all groups experienced some health benefits. Those in the weight loss-resistant group saw improvements in HDL cholesterol and fat distribution, including reductions in visceral fat and leptin. However, they also experienced increases in total cholesterol and fasting glucose.
Participants with moderate weight loss achieved broader improvements, such as better blood pressure, lower triglycerides, reduced liver fat, and improved insulin levels. Those who successfully lost more than 5% of their body weight showed the most substantial improvements across nearly all biomarkers.
Each kilogram of weight lost was associated with meaningful changes in HDL cholesterol, blood pressure, insulin resistance, triglycerides, leptin, and intrahepatic fat. These effects remained significant after adjusting for demographic and trial-related factors, with no differences observed between men and women.
Implications and Limitations
The study reinforces that even small amounts of sustained weight loss can lead to significant cardiometabolic improvements. While only about one-third of participants achieved long-term weight loss, even those who struggled to lose weight experienced some health gains.
Importantly, the study’s methodology—including pooled data, sensitivity analyses, and subgroup testing—adds robustness to the findings. However, the researchers noted several limitations: around 89% of participants were male, limiting the generalizability of the results to women, and the study lacked stratification by specific intervention type.
Moreover, while health improvements occurred in the absence of significant weight loss, some risk factors worsened in the weight-resistant group. This suggests that the benefits of lifestyle changes without weight loss may not be uniform and should be interpreted with caution.
Looking Ahead
The findings highlight the critical role of lifestyle interventions in cardiovascular prevention and provide evidence-based guidance for clinicians. Even when weight loss is modest—or absent—adopting healthy habits can still offer measurable benefits.
Future research should involve larger, more diverse populations, especially women, and further explore omics-based predictors to develop personalized weight loss strategies. Ultimately, promoting healthy behaviors remains vital, even if weight loss is not achieved.
Related Topics
